156 related articles for article (PubMed ID: 23291812)
21. Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.
Lee N; Woodrum CL; Nobil AM; Rauktys AE; Messina MP; Dabora SL
BMC Pharmacol; 2009 Apr; 9():8. PubMed ID: 19368729
[TBL] [Abstract][Full Text] [Related]
22. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
[TBL] [Abstract][Full Text] [Related]
23. Tuberous sclerosis complex and DNA repair.
Habib SL
Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
[TBL] [Abstract][Full Text] [Related]
25. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
Miloloza A; Kubista M; Rosner M; Hengstschläger M
J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
[TBL] [Abstract][Full Text] [Related]
26. Tuberous sclerosis complex: disease modifiers and treatments.
Au KS; Ward CH; Northrup H
Curr Opin Pediatr; 2008 Dec; 20(6):628-33. PubMed ID: 19005330
[TBL] [Abstract][Full Text] [Related]
27. Cardiac fat-containing lesions are common in tuberous sclerosis complex.
Shaaya EA; Hirshberg JS; Rabe OT; Thibert RL; Inglessis I; Sharma A; Thiele EA
Am J Med Genet A; 2013 Jul; 161A(7):1662-5. PubMed ID: 23703751
[TBL] [Abstract][Full Text] [Related]
28. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
[TBL] [Abstract][Full Text] [Related]
29. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.
Gutmann DH; Zhang Y; Hasbani MJ; Goldberg MP; Plank TL; Petri Henske E
Acta Neuropathol; 2000 Mar; 99(3):223-30. PubMed ID: 10663963
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP
Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481
[TBL] [Abstract][Full Text] [Related]
31. Evidence for population variation in TSC1 and TSC2 gene expression.
Jentarra GM; Rice SG; Olfers S; Saffen D; Narayanan V
BMC Med Genet; 2011 Feb; 12():29. PubMed ID: 21345208
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
[TBL] [Abstract][Full Text] [Related]
33. Antenatal screening and diagnosis of tuberous sclerosis complex by fetal echocardiography and targeted genomic sequencing.
Gu X; Han L; Chen J; Wang J; Hao X; Zhang Y; Zhang J; Ge S; He Y
Medicine (Baltimore); 2018 Apr; 97(15):e0112. PubMed ID: 29642139
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetic, cardiac and neurodevelopmental findings in cases of prenatally diagnosed rhabdomyoma associated with tuberous sclerosis complex.
Lee KA; Won HS; Shim JY; Lee PR; Kim A
Ultrasound Obstet Gynecol; 2013 Mar; 41(3):306-11. PubMed ID: 22791573
[TBL] [Abstract][Full Text] [Related]
35. Minimal mosaicism, maximal phenotype: Discordance between clinical and molecular findings in two patients with tuberous sclerosis.
Byers HM; Jensen DM; Glass IA; Bennett JT
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):374-378. PubMed ID: 30260069
[TBL] [Abstract][Full Text] [Related]
36. Tuberous sclerosis as an underlying basis for infantile spasm.
Yeung RS
Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and genetic study patients with tuberous sclerosis complex].
Rubilar C; López F; Troncoso M; Barrios A; Herrera L
Rev Chil Pediatr; 2017 Feb; 88(1):41-49. PubMed ID: 28288225
[TBL] [Abstract][Full Text] [Related]
38. Analysis of genotypes and phenotypes in Chinese children with tuberous sclerosis complex.
Bai D; Zhao J; Li L; Gao J; Wang X
Sci China Life Sci; 2017 Jul; 60(7):763-771. PubMed ID: 28623545
[TBL] [Abstract][Full Text] [Related]
39. Tumour suppressors hamartin and tuberin: intracellular signalling.
Krymskaya VP
Cell Signal; 2003 Aug; 15(8):729-39. PubMed ID: 12781866
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]